EcoDrugPlus

Ribosomal Protein L34

Ensembl ID : ENSFCAG00000015502
Gene Symbol: RPL34
5 Cross references
272 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSFCAG00000030388
Gene Symbol: RPL35
5 Cross references
236 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSFCAG00000041509
Gene Symbol: RPL35A
5 Cross references
182 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSFCAG00000011838
Gene Symbol: RPL36
5 Cross references
174 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSFCAG00000015397
Gene Symbol: RPL36A
3 Cross references
83 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSFCAG00000035948
Gene Symbol: RPL37
4 Cross references
165 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSFCAG00000010851
Gene Symbol: RPL38
2 Cross references
109 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSFCAG00000012293
Gene Symbol: RPL4
5 Cross references
285 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSFCAG00000006858
Gene Symbol: RPL6
5 Cross references
424 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSFCAG00000044737
Gene Symbol: RPL7A
5 Cross references
358 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSFCAG00000026288
Gene Symbol: RPL8
5 Cross references
272 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSFCAG00000012284
Gene Symbol: RPL9
5 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).